Displaying 61 - 90 of 98 in total
Ep. 38: PhD Candidates on the Front Lines of COVID
COVID impacted everyone differently, including early career scientists who found their work resources diverted to COVID research. One such scientist is doctoral candid...
Ep. 37: Ambassadors of Science
Elaine Duncan and Alan Mukuvare are early career scientists who understand the importance of scientific mentors. They themselves have benefited from inspiring STEM men...
Ep. 36: Ziva Abraham, Master Mycologist
For this episode, I am joined by Ziva Abraham, CEO of the pharmaceutical consulting company Microrite. Ziva grew up in India, and fell in love with fungi while studyin...
Ep. 35: COVID and Climate Change
In honor of Earth Day 2021, we speak with Corporate Sustainability experts Gregg Belardo and Erik Mohn about the lessons learned from the COVID-19 pandemic. Some of th...
Ep. 34: Drug Approval in the New Normal
Scientific Advisor Mike Templin joins us to discuss what drug developers have learned from working with the FDA during the pandemic. Where can we improve the relations...
Ep. 33: A Father's Fight
In honor of Rare Disease Month, we are joined by Terry Pirovolakis from CureSPG50.org. Terry's son Michael was born with the ultra-rare SPG50 disease. Listen now to he...
Ep. 32: How to Keep Computers Happy, Chemistry Edition
Yugal Sharma, Ph.D., from CAS and David Clark, Ph.D., from Charles River join us to discuss machine learning in chemistry. We discuss the importance of organizing big ...
Ep. 31: Rare Isn’t Rare: A Conversation With Antonio
Antonio Maltese, a senior studying political science in Virginia, is passionate about advocating for the rare disease community. He belongs to the community himself tw...
Ep. 30: New Partnerships in the New Normal
COVID-19 wreaked havoc with academic labs - students were sent home, campuses were closed, and research projects were delayed or cancelled. Given the critical value of...
Ep. 29: Farm Pharma
Simon Chapleo, an expert in plant metabolism, joins us to discuss agrochemical safety testing and the difficulties of cultivating banana plants in Scotland.
Ep. 28: Building the Building Blocks of Life
Stem cells are a valuable tool in a drug researcher’s shed, but they are notoriously tricky and time consuming to grow. The biotech company Bit Bio hopes to change tha...
Ep. 27: My Rare Disease Does Not Define Me
Gracie van Brunt – singer, songwriter, and rare disease survivor – joins us for a candid interview about her life, career, and experiences with growing up rare.
Ep. 26: From Rabbit to Crab to the Lab
Foster Jordan knows a thing or two about horseshoe crabs, and isn't afraid to share his opinion! Listen now to learn about the future of endotoxin testing, and the pot...
Ep. 25: Tuning the CAR T
With chimeric antigen receptor T-cell (CAR T) therapy, patients’ own immune cells can be “souped up” and used as a cancer treatment. This immunotherapy and its variant...
Ep. 24: Collaborating to Cure Dementia
Dementia is a tricky disease with no cure and precious few treatments. Join host Mary Parker and biologist Sarah Almond to learn about the Dementia Consortium, a publi...
Ep. 23: What is Corporate Sustainability?
What does corporate sustainability mean for the pharmaceutical industry? Gregg Belardo, Senior Director for Corporate Sustainability at Charles River, discusses the “n...
Ep. 22: Brother helping brother to cure Rare Disease
Rich Horgan and Karen Morales from the nonprofit biotech Cure Rare Disease join host Mary Parker to discuss their work. Rich’s brother Terry has a rare form of muscula...
Ep. 21: This Medicine is for the Birds
How can we keep animals healthy without antibiotics? In this episode we talk with avian expert Nastassja Ortega, who develops therapies to protect her chickens from di...
Ep. 20 Tumors and their Entourage: Exploring the Tumor Microenvironment
Join host Mary Parker as she interviews Rhiannon Jenkinson, Director of Science for Discovery Services at Charles River’s Portishead site, about this fascinating and f...
Ep. 19: What’s Hot in 2020: AI and Biomarkers
At the end of 2019, we wanted to take time to predict some of the hot research trends for the coming year. Many companies are taking up the challenge to reduce the tim...
Ep. 18: Speed vs. Safety: Rapid Approvals from the FDA
Genome mapping has made personalized medicine achievable, but how can the FDA balance safety requirements with the speed that is necessary for desperate patients?
Introducing Vital Science
Life science is complicated, but its mission is simple – to create a safer, healthier future. From Charles River, meet Vital Science, the podcast that tells the storie...
Ep. 17: Noteworthy News on Neuroinflammation (Eureka's Sounds of Science)
Central nervous system (CNS) diseases are well known for being tricky to treat and difficult to research. However, some researchers are getting excited about the possi...
Ep. 16: The Quest to Cure Quincy (Eureka's Sounds of Science)
Dr. Allyson Berent speaks with us about her work to find a cure for her daughter’s rare disease.
Ep. 15: Horseshoe Crabs: Natures First Historian (Eureka's Sounds of Science)
Herodotus may be the first human historian, but to travel farther back in time we need our fossil friends, the horseshoe crab.
Ep. 14: Open Science vs. Free Market (Eureka's Sounds of Science)
Can free data and for-profit research coexist?
Ep. 13: Biological Bandages for Animals (Eureka's Sounds of Science)
How California veterinarian Jamie Peyton uses tilapia skins to heal four-legged burn victims, including those hurt in the California wildfires.
Ep. 12: Stage IV (Eureka's Sounds of Science)
One woman describes the messy reality of living with stage IV cancer.
Ep. 11: Herd Immunity (Eureka's Sounds of Science)
How vaccines can protect everyone if enough people get them. A conversation with microbiologist Ken Henderson.
Ep. 9: A Motion Capture Tool for Huntington’s (Eureka's Sounds of Science)
A tool that seems inspired by Hollywood animation imagery allows us to accurately model and measure subtle movements in rodent models of CNS disease.